Colombia: Khiron Receives Cultivation Quota from Colombian Government and Commences Cultivation of Medical Cannabis Strains

Dec 29, 2017 | Hailey Wahlberg, Investing News
View Original

Khiron Life Sciences Corp. reports that the Company’s wholly owned subsidiary, Khiron Colombia SAS, has commenced cultivation of a variety of medical grade cannabis strains in accordance with the receipt of its medical cannabis quota allocation provided by the Government of Colombia. The Company’s cultivation activities are focused on the cultivation of strains specifically targeting patients identified as having unmet medical needs within the Colombian market of 50 million people and the Latin America market of 620 million people. The Company has acquired a full suite of medical cannabis genetics including tetrahydrocannabinol (“THC”) and cannabidiol (“CBD”) strains.